A substantial body of evidence has been presented recently that indicates that the release of mediators from rat mast cells is closely linked to changes in phospholipid metabolism (1-3). Selectively increased incorporation of a2po4 into mast-cell phosphatidic acid (PA), phosphatidylcholine (PC), and phosphatidylinositol (PI) has been shown to occur after stimulation by anti-IgE, concanavalin A, the polycationic histamine-releasing agent compound 48/80, or the calcium ionophore A23187. Studies of the kinetic and dose-response relationships (1), as well as the pharmacologic modulation of these biochemical and functional responses (3), strongly suggest that they are intrinsically related processes. Because 1,2-diacylglycerol (DAG) is a precursor for each of these phospholipid molecules, a possible central role for DAG has been postulated to account for the stimulated changes in mast-cell lipid metabolism (1). The experiments described in this report were designed to determine the levels of DAG during mediator release from mast cells and to probe the metabolic fate of newly formed DAG.
with [3H]arachidonic acid (10 #Ci/10 ~ cells) for 30 min at 37°C. The labeled cells were washed twice, resuspended (1.5 X 10S/ml), and 3 X 105 cells were aliquoted into polypropylene tubes. Mast-cell lipids were extracted at varying times after stimulation with compound 48/80 (1 #g/ ml final concentration in a final vol of 0.25 ml) by the addition of 1.65 ml of chloroform/ methanol~0.267 N HCI (1:2:0.3). After 30 min at room temperature, insoluble material was removed from the extract by centrifugation. The supernates were added to tubes containing unlabeled marker lipids (20 #g each of monolein, 1,2-diolein, arachidonic acid, triolein, and phosphatidic acid) and after thorough mixing, two phases were obtained by centrifugation and the upper, aqueous phase was discarded. The organic phase was dried and the lipids (dissolved in 0.05 ml of chloroform) were separated by TLC (hexane/diethylether/acetic acid; 30: 70:1). Lipid-containing areas (detected by iodine staining) were cut out of the TLC plate, placed in Minivials (Fisher Scientific Co., Pittsburgh, Pa.), and the radioactivity assessed after the addition of Scintiverse (Fisher Scientific Co.).
Isolation and Quantitation of Mast-Cell DAG. Cellular lipids were extracted by the addition of 1.5 ml of chloroform~methanol~12 N HC1 (50:100:0.33) at varying times after mast cells (106 cells in 0.4 ml) were stimulated by compound 48/80. Insoluble material was removed by centrifugation after 30 rain at room temperature. After the addition of 0.5 ml chloroform and 0.5 ml of 0.1 N HCI and mixing, two phases were obtained by centrifugation. No detectable acid-catalyzed hydrolysis of phospholipids to DAG was detected. The lipid residue obtained by drying the lower phase was dissolved in 0.10 ml of 5% (vol/vol) ether in hexane and applied to a 0.075-ml silicic acid column equilibrated in the same solvent. Contaminating neutral lipids were eluted by the addition of two 0.20-ml vol of 12.5% (vol/vol) ether in hexane. The DAGcontaining fraction was eluted by the addition of two 0.20-ml vol of 50% (vol/vol) ether in hexane. After evaporating the solvent, DAG was quantitated by DAG kinase-catalyzed phosphorylation as described in detail in a separate communication (4) . Briefly, DAG kinase 
Analysis of Data.
All experiments were performed in triplicate and data are presented as mean _ SEM. Significance was assessed using the independent Student's t test (two-tailed). No differences were noted within 15 s after the addition of compound 48/80, but significant elevation of labeled DAG was detected within 1 min after stimulation. The relatively small absolute label accumulation in DAG (250-300 cpm) when compared to prestimulation levels of labeled PI, PC, PE, and triglyceride (7,600, 21,000, 4,800, and 4,300 cpm respectively) precluded demonstration of an absolute loss of label in any of these potential precursor lipids.
Results

DAG in Mast
Although these results suggested that levels of DAG increase in stimulated mast cells, the elevated labeling of DAG could have been the result of an increase in the specific activity of DAG. To resolve this issue, levels of DAG in mast cells were assayed directly. The absolute levels of DAG increased in stimulated mast cells in parallel Labeled DAG was dispersed and l0 s mast cells broken by sonication. After 15 min at 37°C, lipid-soluble products were obtained by extraction and separated by TIC as described in Methods. The amount of label comigrating with authentic standards was determined and the percentage of the contribution of each lipid class to the total quantity of newly formed labeled products was calculated for each experiment. Data represent mean ± SEM of means obtained in three different experiments (total labeled productsi 542 ± 67 pmol/15 rain per 105 cells).
with the increase in DAG labeling seen with [~H]arachidonate-labeled cells (Fig. 1) . Significantly elevated DAG levels were observed I, 3, and 10 min after the addition of compound 48/80 (stimulation ratios of 2.2, 2.29, and 3.07, respectively; P <0.001).
Fate of DAG in Mast-Cell Homogenates. The metabolism of DAG was examined in broken-cell preparations of mast cells as described in Methods. The major metabolic product obtained from labeled DAG was free arachidonic acid (Table I) . Substantial formation of labeled triglycerides, phospholipids, and monoacylglycerol also was detected. Further analysis of free arachidonic acid formation was assessed as illustrated in Fig. 2 . The data presented in Fig. 2A demonstrate that the production of unesterified arachidonate was linearly dependent upon the amount of mast-cell homogenate present during the incubation. When mast cells were heated (100°C for 5 min) before their disruption, no arachidonate was released from labeled DAG (not shown). Fig. 2 B illustrates the rate of free arachidonic acid formation under these experimental conditions. The release of free arachidonate was constant for the first 5 min (220 pmol/min per 106 mast cells), declining steadily thereafter. Interestingly, when 2-[1-14C]arachidonyl-phosphatidylcholine was used as substrate, instead of 
DAG lipase activity in mast cells. (A) Dispersions of 2-[14C]arachidonoyl-DAG (O) or 2-[14C]arachidonoyl-phosphatidylcholine (O)
were incubated for 30 min with varying quantities of sonicated mast cells. Lipid-soluble products were extracted, separated, and radioactivity determined as described in Methods. The rate of arachidonate release was calculated (after subtracting the quantity of labeled arachidonic acid produced in the absence of added mast-cell sonicates) using the specific activity of the radioactive substrate (1.34 mCi/mmol). Data represent mean + SEM of triplicate observations made in one of two similar experiments. (B) Labeled DAG was sonicated with mast cells and aliquots (containing 106 cells) were removed at the times indicated and the lipids extracted immediately as described in Methods. Release of labeled arachidonate was determined after TLC separation of lipid classes and expressed as mean ± SEM of triplicate values. In a second experiment, the initial rate of arachidonate release was 773 ± 61 pmol/h per 105 cells.
labeled DAG derived from this same PC, no release of labeled arachidonic acid was detected at any homogenate concentration examined.
Discussion
The results of this study demonstrate that DAG levels are significantly elevated in stimulated mast cells. When mast cells were prelabeled with [SH]arachidonic acid, washed, and stimulated, levels of labeled DAG were found to rise ~threefold (Fig. 1 ) coincident with active secretion (8) . Quantitative analysis of mast-cell DAG demonstrated that whole-cell levels of DAG rise two-to threefold during secretion with kinetics parallel to those observed in the labeling studies (Fig. 1) .
Because DAG has been found to be fusogenic (i.e., to cause or enhance membrane fusion) (9) and is associated with membrane fusion in erythrocytes (10, 11) , the increased levels of DAG in stimulated mast-cell membranes may play a role in the fusion process that leads to the release of preformed mediators during secretion. These observations are in accord with the hypothesis (1) that elevated S~PO4 incorporation into PI, PA, and PC in mast cells occurs as a result of enhanced DAG production and may in part reflect negative regulation of secretion by reducing DAG levels.
The origin of this newly formed DAG is not yet established. De novo synthesis of DAG seems unlikely because radiolabeled glucose or glycerol are not acutely incorporated into this newly formed DAG (D. A. Kennerly, B. Tung, and T. J. Sullivan. Manuscript in preparation.). The actions of phospholipase C, phosphatidate phosphohydrolase, or triglyceride lipase on their respective substrates appear to be the most likely mechanisms of DAG formation.
The absence of a rise in DAG levels within 3-8 s after stimulation is interesting because increased a2PO4 incorporation into PA is detectable at that time (1) . Early PA formation may occur as a result of phospholipase D action on phospholipids followed by a secondary conversion to DAG by the action of a phosphatidate phosphohydrolase. Alternatively, mast-cell DAG kinase may initially remove newly formed DAG (by phosphorylation to form PA) until stimulated DAG production exceeds this enzyme's capacity, thereby resulting in abruptly increased levels of DAG. Preliminary data (not shown) demonstrate the existence of a mast-cell DAG kinase, but information regarding the mast-cell metabolic pathways that utilize DAG is incomplete.
Studies of the fate of 2-[1-a4C]arachidonoyl-DAG in broken-cell preparations of mast cells demonstrated that free arachidonate is a major product of the action of mast-cell enzymes on arachidonic acid-containing DAG. This hydrolytic activity was time dependent, proportional to the quantity ofsonicated mast-cell suspension present (Fig. 2) , and was abolished by heating the mast-cell preparations to 100°C, indicating that the hydrolysis is probably an enzymatic process. The absence of labeled arachidonate production when labeled phosphatidylcholine was used as substrate ( Fig. 2 A) indicates that the lipolytic activity in mast-cell homogenates preferentially cleaved fatty acids from DAG and suggests the presence of more DAG-lipase activity than phospholipase A2 activity. A systematic evaluation of mast-cell phospholipase A2 activity would be valuable to determine the relative importance of these two arachidonate-generating pathways. The ability of mast cells to convert DAG to fatty acid and monoacylglycerol may be of considerable importance in the membrane fusion process, because these moieties are more fusogenic than DAG itself (9) .
In the studies of Lewis et al. (12) , A23187-stimulated mast cells produced ~200 pmol of arachidonate products/106 cells over a 30-min period (12) . In this study, DAG lipase activity in mast-cell homogenates was capable of hydrolyzing 220 pmol arachidonic acid/min per 10 6 cells from DAG. The DAG lipase activity demonstrated in these studies would be sufficient to account for the level of arachidonate-metabolite formation known to occur. Sl.llTlmary Purified rat peritoneal mast cells stimulated with the polycationic histaminereleasing agent compound 48/80 demonstrated a two-to fourfold increase in cellular levels of 1,2-diacylglycerol (DAG) within 1 min as detected by radioactive labeling and direct quantitation experiments. When 2-[1-14C]arachidonoyl-DAG was incubated in the presence of mast-cell homogenates, a rapid conversion to free arachidonate, and to a lesser extent, to monoacylglycerol, triglyceride, and phospholipid was observed. The release of arachidonate was proportional to the amount of broken-cell preparation added and the time of incubation, was prevented by preheating mast-cell preparations, and did not occur when 1-[1-14C]arachidonoyl-phosphatidylcholine was used as substrate, suggesting that the degradation was mediated by an enzyme with DAG-lipase activity. Although much work remains to be done to clarify the precise role of DAG in mast cells, DAG metabolism may be involved in secretion by generating substances which may facilitate membrane fusion and also in arachidonic acid-derived mediator formation by liberating esterified arachidonic acid from mastcell lipids. Taken together, these studies indicate that the formation of DAG may play a central role in mast-cell function.
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